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During vertebrate retinogenesis, the precise balance between retinoblast proliferation and differentia-
tion is spatially and temporally regulated through a number of intrinsic factors and extrinsic signaling
pathways. Moreover, there are complex gene regulatory network interactions between these intrinsic
factors and extrinsic pathways, which ultimately function to determine when retinoblasts exit the cell
cycle and terminally differentiate. We recently uncovered a cell non-autonomous role for the intrinsic
HLH factor, Id2a, in regulating retinoblast proliferation and differentiation, with Id2a-deﬁcient retinae
containing an abundance of proliferative retinoblasts and an absence of terminally differentiated retinal
neurons and glia. Here, we report that Id2a function is necessary and sufﬁcient to limit Notch pathway
activity during retinogenesis. Id2a-deﬁcient retinae possess elevated levels of Notch pathway compo-
nent gene expression, while retinae overexpressing id2a possess reduced expression of Notch pathway
component genes. Attenuation of Notch signaling activity by DAPT or by morpholino knockdown of
Notch1a is sufﬁcient to rescue both the proliferative and differentiation defects in Id2a-deﬁcient
retinae. In addition to regulating Notch pathway activity, through a novel RNA-Seq and differential gene
expression analysis of Id2a-deﬁcient retinae, we identify a number of additional intrinsic and extrinsic
regulatory pathway components whose expression is regulated by Id2a. These data highlight the
integral role played by Id2a in the gene regulatory network governing the transition from retinoblast
proliferation to terminal differentiation during vertebrate retinogenesis.
& 2012 Elsevier Inc. All rights reserved.Introduction
The retina is composed of distinct and specialized neuronal
and glial cell types that are generated with spatial and temporal
precision during embryonic development. The mature retina
contains seven differentiated cell types: ganglion cells, amacrine
cells, bipolar cells, horizontal cells, rods, cones and Mu¨ller glia.
These cells are organized into precise laminae—the ganglion cell
layer (GCL), inner nuclear layer (INL) and the outer nuclear layer
(ONL) (Dowling, 2012). During retinogenesis each retinal cell type
develops from a common pool of retinal progenitor cells located
in the inner neuroblastic layer of the optic cup. Cell fate speciﬁca-
tion and commitment mechanisms bias retinal progenitors intoll rights reserved.
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ross).distinct cell fates that are executed upon terminal differentiation
(reviewed in Zaghloul et al., 2005; Agathocleous and Harris, 2009).
Cell fate speciﬁcation and terminal differentiation are spatially
regulated, beginning in the ventral-nasal retina and sweeping
around dorsally and temporally in a fan-like fashion (Hu and
Easter, 1999; Schmitt and Dowling, 1994). Similarly, temporal
components of retinogenesis are highly regulated in all vertebrates
where the GCL is the ﬁrst to differentiate, followed by the INL and
then the ONL. Finally, balancing proliferation and differentiation,
neurogenic waves in the retina are coupled to intervening phases
of proliferation that serve to maintain the retinoblast progenitor
population for subsequent waves of neurogenesis (Hu and Easter,
1999). Together, all of these events are exquisitely coordinated in
order to generate a mature retina of the proper size and neuronal/
glial composition.
From numerous studies, a model has emerged for the speciﬁ-
cation, commitment and differentiation of retinal cell types
that involves both intrinsic and extrinsic factors (Cepko, 1999;
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Harris, 2009). Speciﬁcation events serve to bias a group of
competent cells toward a limited number of fates, whereas
commitment events restrict a group of speciﬁed cells toward a
single cell fate, enabling differentiation of specialized cell types to
then occur. Intrinsically, speciﬁcation events are primarily
mediated by transcription factors such as Pax6, Six3b and Foxn4
(Harada et al., 2007; Luo et al., 2012; Zaghloul et al., 2005). Cell
commitment to a neuronal lineage then requires the expression
and function of neurogenic family transcription factors such as
NeuroD4, Atoh7, Ap2a and NeuroD (Bassett et al., 2012; Luo et al.,
2012; Zaghloul et al., 2005). Finally, differentiation involves the
activity of additional factors such as the Histone modifying factors
Brg-1 and Histone deacetylase1(Gregg et al., 2003; Yamaguchi
et al., 2005). Extrinsically, the Notch, Sonic Hedgehog, Fibroblast
growth factor and Wnt signaling pathways have all been shown
to inﬂuence proliferation of the retinal progenitor cell population
as well as the speciﬁcation, commitment and differentiation of
neuronal lineages within the vertebrate retina (Cepko, 1999;
Martinez-Morales et al., 2005; Murali et al., 2005; Zhang and
Yang, 2001). Gene regulatory network interactions between
intrinsic factors and extrinsic pathways are complex; extrinsic
signaling pathway activity often leads to changes in the expres-
sion or distribution of the intrinsic factors, while intrinsic reg-
ulators are capable of modulating the extrinsic signaling
pathways (Luo et al., 2012; Yamaguchi et al., 2005).
Previously, we identiﬁed the intrinsic factor Id2a as a regulator
of zebraﬁsh retinal development (Uribe and Gross, 2010).
Embryos in which Id2a expression was blocked by morpholino-
mediated knockdown (‘‘Id2a-deﬁcient’’) were microphthalmic,
yet retinal progenitors remained proliferative and failed to
efﬁciently exit the cell cycle or terminally differentiate in Id2a-
deﬁcient retinae. Id2a’s role in both of these processes was cell
non-autonomous, indicating that Id2a function was required
upstream of extrinsic regulators of retinal development. In the
present study, we explore the cell non-autonomous role of Id2a
further, and present data demonstrating that Id2a function is
necessary and sufﬁcient to limit Notch pathway activity during
retinogenesis, thereby modulating retinoblast proliferation and
terminal differentiation. Utilizing a novel, unbiased RNA-seq
approach, we also identiﬁed additional gene products whose
expression is dependent on Id2a. These data position Id2a as a
key factor in the gene regulatory network regulating proliferation
and differentiation during retinogenesis and identify a number of
pathways inﬂuenced by Id2a during retinal development.Materials and methods
Fish care
Zebraﬁsh (Danio rerio) were maintained at 28.5 1C on a 14 h
light/10 h dark cycle. Animals were treated in accordance with
University of Texas at Austin IACUC provisions.
Morpholino and mRNA injections
All morpholinos and mRNAs were co-injected with ﬂuorescein
dextran (Invitrogen) at the 1–4 cell stage as a lineage tracer to
ensure ubiquitous distribution/expression. The following morpho-
linos were used: Id2aMO (50-GCCTTCATGTTGACAGCAGGATTTC-30)
(Uribe and Gross, 2010), Id2a mismatch morpholino (Id2aMM)
(50-GCGTTGATGTTCACAGCACGAATTC-30) (Uribe and Gross, 2010)
and Notch1aMO (50-GAAACGGTTCATAACTCCGCCTCGG-30) (Lorent
et al., 2004; Bill et al., 2008; Ishitani et al., 2010). The knockdown
efﬁcacy of Id2aMO was reported in Uribe and Gross (2010). For gfpand id2a mRNA injections, pCS2-id2a and pCS2-gfp (Uribe and
Gross, 2010) were linearized and capped mRNAs were transcribed
using the mMessage kit (Ambion). 100 pg of id2a mRNA was
injected into embryos for overexpression experiments.
Retinal RNA extraction and puriﬁcation
From Id2aMM and Id2aMO injected embryos, 50 whole retinae
(lenses removed) were dissected between 48 and 50 hpf in sterile
Ringer’s solution (116 mM NaCl, 2.9 mM KCl, 1.8 mM CaCl2,
5.0 mM HEPES, pH 7.2). Dissected retinae from each condition
were immediately pooled and dissolved in 1 mL of Trizol reagent
(Invitrogen) and brieﬂy vortexed at room temperature. Total
retinal RNA was puriﬁed by the addition of 200 mL of chloroform,
the samples were vortexed for 1 min and then centrifuged for
5 min, 16,000 g at 4 1C. The resulting aqueous layer was trans-
ferred to a new tube, mixed with an equal volume of RNase-free
70% ethanol, loaded into an RNeasy MiniElute kit column (Qiagen)
and centrifuged for 15 s, 8000 g at 4 1C. The column was washed
twice with 700 mL of RPE buffer supplied in the RNeasy MiniElute
kit; samples were centrifuged for 30 s, 8000 g at 4 1C in between
each wash. The column was given a ﬁnal wash with 700 mL of
RNase-free 80% ethanol and centrifuged for 2 min, 8000 g 4 1C.
To remove all residual ethanol from the column, it was centri-
fuged at top speed for 5 min and the RNA was eluted with 16 mL
of RNase-free water. Resulting RNA was subjected to RNA
integrity analyses using an Aligent BioAnalyzer, and only sam-
ples having an RNA integrity number (RIN) of 9 or higher were
used for subsequent RNA-sequencing analyses or quantitative
real time PCR.
RNA sequencing
RNA sequencing was performed using the Illumina HiSeq 2000
at the Genome Sequencing and Analysis Facility, UT Austin. Two
biological replicates were performed for Id2aMM control and
Id2aMO knockdown conditions. A starting amount of 1 microgram
of total retinal RNA per condition was used to generate cDNA
libraries using the TruSeq RNA Sample Prep kit (Illumina).
Sequencing results have been submitted to the Gene Expression
Omnibus database (Accession number: GSE38786).
Short read mapping and differential expression analysis
RNA-seq reads were mapped to all known 48,636 D. rerio
cDNA sequences (EnsEMBL release 66) using bowtie (version
0.12.7) (Langmead et al., 2009), with the option to report all
alignments per read. Approximately 46–52% of total reads (43–57
million reads) were mapped to the cDNA database. While this
approach can inﬂate absolute abundance estimation for transcript
isoforms or paralogous genes in the genome by counting shared
reads among them multiple times, it should not introduce
signiﬁcant bias in relative abundance analysis performed in this
study, mainly because the identical cDNA database is used in a
comparison between two samples (Id2aMM vs. Id2aMO). The
number of reads per each transcript was normalized with total
number of mapped reads and transcript length, converting all raw
read counts to ‘number of reads per 1000 bases per 100 million
reads’ (RPK100M). ‘100 million reads’ was chosen as a normal-
ization factor, instead of the conventional 1 million reads (RPKM)
(Mortazavi et al., 2008), to generate positive values of log10-
transformed normalized values. Transcripts without any mapped
reads in more than two biological samples were discarded, then
mapped transcripts were rounded to an integer using DESeq
package (version 1.6.1) (Anders and Huber, 2010) to identify
differentially expressed genes between Id2aMM and Id2aMO
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than a 0.05 adjusted p-value between Id2aMM and Id2aMO
samples were deﬁned as differentially expressed (DE) genes.
Functional enrichment analysis
DAVID (version 6.7) (Huang da et al., 2009a,b) was used for
functional enrichment analysis. Genes identiﬁed in this experi-
ment were used as background (Supplemental Table 1) and tested
for which functional groups are enriched in either up-regulated
genes or downregulated genes in Id2aMO compared to Id2aMM
(Supplemental Table 2). Out of 24,506 background genes (43,155
transcripts), 18,232 genes were successfully submitted to the
DAVID server as background. Similarly, 720 out of 871 down-
regulated genes and 312 out of 384 up-regulated genes were used
in this test. The Gene Ontology (GO) terms in three categories,
InterPro protein domain and KEGG pathways with at least three
member were considered, and enriched functional categories
were determined by o0.05 adjusted p-value (Benjamini)
(Supplemental Tables 3 and 4).
Quantitative RT-PCR (qRT-PCR)
The following qPCR primers were used: tubulin, alpha 1
50-TGGAGCCCACTGTCATTGATG-30 and 50-CAGACAGTTTGCGAAC-
CCTATCT-30 hes6 50-CGAAGGAGGCTGACAGTGTG-30 and 50-ATTC-
GAGGAGGTGGTTCAGC-30, her4.1 50-CACTGGATCAATCAGCAGCA-30
and 50-TCTCGGCGGATCTTCTCC-30, dla 50-GATCGACCACTGCTCTTC-
CA-30 and 50-TTGGCAAGGGTACATCGAAC-30, ascl1a 50-GGGCT-
CATACGACCCTCTGA-30 and 50-TCCCAAGCGAGTGCTGATATTT-30,
notch1a 50-ACATCACCCTTCCAGCAGTC-30 and 50-AGGCTTCCCTAAA-
CCCTGAA-30, cdk6 50-CCTACTTCGTTTCCTGTCCTTC-30 and 50-TAC-
AGGCTCTTGCTGGTGCT-30, skp2 50-AAAGCACACCGAGTCTTCGT-30
and 50-CAGAGAGCACCAATCCTTCA-30, cdkn1a 50-AGAAGAGCAGC-
GAGCTGAAG-30 and 50-TAGACGCTTCTTGGCTTGGT-30, fzd6 50-
GCAGTGTGAGCGACTGGAG-30 and 50-TTAGCTGGAGCGGACACC-30,
rspo1 50-GATCCCATGCAAAGGAGAAA-30 and 50-GTGGTGGACCGGT-
TAGTGTT-30, tcf7l1b 50-CTCACCTCGTCCCTCATCAT-30 and 50-GGC-
CTGGAGACTTCGTGTTA-30. Real time PCR experiments were per-
formed in triplicate (three biological replicates) using Power SYBER
Green PCR Master Mix (Applied Biosystems) and an Applied
Biosystems 7900HT real time PCR machine. Real time PCR data
was analyzed using the Comparative Ct method (Schmittgen and
Livak, 2008). Statistical signiﬁcance was determined using a
Student’s T-test (GraphPad Prism).
In situ hybridization
Hybridizations using digoxigenin labeled antisense RNA
probes were performed essentially as described (Jowett and
Lettice, 1994). The cDNA clones containing dla and her4.1 were
purchased from ZIRC (Eugene, OR) and cDNA clones containing
ascl1a and notch1a were kindly provided by Bruce Riley (Texas
A&M University). For comparisons between samples (e.g., control
and experimental samples), in situs were developed in parallel,
using identical reagents, probes, etc., and reactions were stopped
at the same time for both samples.
Immunohistochemistry
Immunohistochemistry was performed as described in (Uribe
and Gross, 2007). The following antibodies and dilutions were used:
anti-pH3 (1:250) (06-570, Millipore), anti-BrdU (1:250) (ab6326,
Abcam), zpr1 (1:200) (ZIRC), 5e11 (1:100) (gift of Dr. James Fadool,
Florida State University) and goat anti-mouse, anti-rabbit or anti-rat
secondary antibodies (1:200, Jackson ImmunoResearch). Nucleiwere counterstained with SytoxGreen (1:10,000; Molecular Probes).
For BrdU analyses, dried cryosections were ﬁrst rehydrated in PBST,
incubated in 4 N HCl for 12 min at 37 1C and then washed three
times in PBST before incubation in block.
DAPT treatment
InsolutionTM g-Secretase Inhibitor 1 DAPT Stock solution
(Calbiochem) (25 mM DAPT dissolved in DMSO) or DMSO alone
was used for all experiments. Embryos were incubated in ﬁsh water
supplemented with either 50 mM DAPT or DMSO as a control. After
incubation, embryos were extensively washed in ﬁsh water prior to
ﬁxation in 4% PFA.Results
Id2a-deﬁcient (Id2aMO-injected) retinoblasts remain prolif-
erative and fail to terminally differentiate and these defects result
from a cell-non autonomous function of Id2a, indicating that Id2a
acts upstream of extrinsic regulators of retina development (Uribe
and Gross, 2010). These phenotypes are reminiscent of the effects
of sustained Notch pathway activity on retinal development and
therefore, we hypothesized that Notch pathway activity may be
regulated by Id2a. To begin to test this hypothesis, Notch pathway
activity was globally inhibited in Id2a-deﬁcient embryos using
the gamma-secretase inhibitor, DAPT (Geling et al., 2002).
Embryos treated with DAPT exhibited phenotypes characteristic
of Notch inhibition, i.e., disrupted somite morphology (Geling
et al., 2002; Amsterdam et al., 2004; van Eeden et al., 1996; data
not shown), and, in the retina, an expansion of RGCs (Supp. Fig. 1;
Bernardos et al., 2005). Id2aMM and Id2aMO injected embryos
were treated with DMSO (vehicle control) or DAPT from
28–48 hpf, subjected to a 30 min BrdU pulse at 48 hpf, and then
immediately sacriﬁced and processed for BrdU immunohisto-
chemistry. As expected, Id2aMM control embryos treated with
DMSO contained a low proportion of BrdU-positive cells in their
retinae (15%; Fig. 1F), and these BrdU-positive cells were localized
largely at the marginal zones (Fig. 1A). DMSO-treated Id2aMO
retinae possessed a signiﬁcantly higher proportion of BrdU-
positive cells (53%, p¼0.0004), and these were distributed ecto-
pically throughout the central retina (Fig. 1B and F). Id2aMO
retinae also contained signiﬁcantly fewer cells than Id2aMM
retinae, as previously shown (Fig. 1E) (p¼ .03) (Uribe and Gross,
2010). Treatment of Id2aMM embryos with DAPT decreased
retinal cell number slightly, likely due to elevated apoptosis
(Bernardos et al., 2005), but DAPT had no effect on BrdU
incorporation (Fig. 1C and F). Treatment of Id2aMO embryos with
DAPT, however, rescued proliferation defects (Fig. 1D and F);
Id2aMO retinae displayed a signiﬁcant reduction in BrdU-positive
cells when compared to DMSO controls (28%; p¼ .0014), and
proliferative cells were largely limited to the retinal periphery as
in Id2a-MM controls (Fig. 1D and F). In addition, total retinal cell
number was signiﬁcantly rescued (p¼0.04), and comparable to
that of Id2aMM-DAPT embryos (Fig. 1E).
Given that inhibition of the Notch pathway rescued prolifera-
tion defects in Id2a-deﬁcient retinae, we were curious if inhibi-
tion would also be sufﬁcient to restore the presence of terminally
differentiated neurons in Id2a-deﬁcient retinae. To assay terminal
differentiation, Id2aMM and Id2aMO embryos were treated with
DMSO or DAPT from 28–72 hpf, and at 72 hpf, immunohisto-
chemistry for 5e11 was used to assay for the presence of
terminally differentiated amacrine cells (Hyatt et al., 1996;
Fadool et al., 1999), or for Zpr1, which detects red/green cone
cells (Larison and BreMiller, 1990). As expected, DMSO-treated
Id2aMM retinae differentiated amacrine cells and red/green cones
Fig. 2. DAPT inhibition of the Notch pathway rescues terminal differentiation in Id2a-deﬁcient retinae. Transverse retinal sections at 72 hpf from Id2aMM-DMSO (A)–(D),
Id2aMM-DAPT (F)–(I), Id2aMO-DMSO (J)–(M) and Id2aMO-DAPT (N)–(Q) embryos. Embryos were treated with DMSO or DAPT from 28–72 hpf. Amacrine cells marked by
5e11 (A), (F), (J) and (N) and red/green cones marked by Zpr1 (C), (H), (L) and (P) fail to differentiate in Id2aMO retinas treated with DMSO (J), while in Id2aMO retinas
treated with DAPT, both amacrine cells and red/green cones are detected (N) and (P). Merged images show co-staining of retinal marker (red) and nuclei (Sytox-green;
green). Dorsal is up in all images.
Fig. 1. DAPT inhibition of the Notch pathway rescues proliferation defects in Id2a-deﬁcient retinae. (A)–(D) Id2aMM and Id2aMO embryos treated with either (A) and (B)
DMSO or (C) and (D) DAPT from 28–48 hpf and pulsed with BrdU for 30 min prior to ﬁxation. Transverse retinal sections showing BrdU-positive cells at 48 hpf (red).
Quantiﬁcation of average cell number per retinal section (E) and the proportion of BrdU-positive cells per retinal section (F) at 48 hpf. Nuclei are stained with Sytox-green
(cyan). Dorsal is up in all images. Error bars represent SEM, n¼9; *po0.05, **po0.005.
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Fig. 3. Notch pathway component gene expression is upregulated in Id2a-
deﬁcient retinae. (A) qRT-PCR quantiﬁcation of 48 hpf dla, dlc, her4.1, hes6, n1a
and ascl1a levels in Id2aMO and Id2aMM retinae. Transcript levels were normal-
ized to tubulin, alpha 1 and the fold-change in expression in Id2aMO vs. Id2aMM
presented. Error bars represent SEM, **po0.05, n¼3 biological replicates.
(B) Transverse sections reveal the expression domains for ascl1a, notch1a and
deltaA in Id2aMM and Id2aMO embryos at 48 hpf following in situ hybridization
(n¼6 sectioned embryos/condition).
R.A. Uribe et al. / Developmental Biology 371 (2012) 280–292284normally (Fig. 2A–D). DAPT-treatment resulted in elevated cell
death and retinal lamination defects in these embryos, but this
did not prevent the terminal differentiation of amacrine cells or
red/green cones (Fig. 2F–I). Also as expected, Id2aMO retinae
treated with DMSO failed to differentiate amacrine cells and
red/green cones (Fig. 2J–M); however, when treated with DAPT,
Id2aMO retinae exhibited a striking rescue of neuronal differen-
tiation; both amacrine cells and red/green cones were present
(Fig. 2N–Q). As with DAPT-treated controls, lamination was
abnormal in retinae from DAPT treated Id2aMO embryos, but
amacrine cells and cone photoreceptors nonetheless terminally
differentiated. These data indicate that inhibition of Notch path-
way activity is sufﬁcient to rescue proliferation and terminal
differentiation defects resulting from a loss of Id2a function and
suggests that elevated Notch pathway activity could underlie
some of the cell non-autonomous effects of Id2a loss of function
on retinogenesis.
To determine if Id2a levels inﬂuence Notch pathway gene
expression, quantitative real-time PCR (qRT-PCR) was used to
quantify the expression of Notch pathway genes in Id2aMM and
Id2aMO retinae. Here, retinae were isolated from Id2aMM and
Id2aMO embryos at 48 hpf and the expression levels of achaete-
scute complex-like1a (ascl1a), notch1a (n1a), deltaA (dla), deltaC
(dlc), hairy-related 4.1 (her4.1) and hairy and enhancer of split 6
(hes6) was assessed. In Id2aMO retinae, the expression of each of
these factors was elevated over that in Id2aMM retinae; the Notch
ligand genes dla and dlc; the Notch receptor gene n1a; and the
Notch pathway target genes ascl1a, her4.1 and hes6 were all
signiﬁcantly upregulated in retinae lacking Id2a (Fig. 3A). More-
over, in situ hybridization for ascl1a, n1a and dla demonstrated
expanded expression domains at 48 hpf in Id2aMO retinae when
compared with Id2aMM controls, which only exhibited expres-
sion of each of these genes within the ciliary marginal zones of
the retina (Fig. 3B). These qRT-PCR and in situ hybridization data,
in conjunction with the results of DAPT inhibition experiments,
support a model in which Notch pathway gene expression is
modulated by Id2a.
To directly examine epistatic interactions between Id2a and
speciﬁc Notch pathway components, we utilized co-knockdown
rescue experiments to determine if, in the absence of Id2a,
removal of a speciﬁc Notch pathway component would also
rescue proliferation and/or terminal differentiation of retinal
neurons. We chose to focus on Notch1a, as its expression was
elevated in Id2a-deﬁcient retinae (Fig. 3). Zebraﬁsh possess two
paralogues (N1a and N1b) and during retinal neurogenesis, n1a
expression is concentrated near the apical surface of the retina
(adjacent to the retinal pigmented epithelium), where Notch
signaling activity is predominately active (Del Bene et al., 2008).
Cell–cell interactions involving Delta ligands and Notch receptors
activate the canonical Notch signaling pathway—this then up
regulates the expression of members of the hairy and enhancer of
split (Hes) family, which serve to inhibit the expression of
proneural genes to inhibit differentiation (Bae et al., 2000;
Perron and Harris, 2000). Morpholino knockdown of N1a alone
reduced the expression domain of the Notch reporter gene her4.1
at 24 hpf (Supp. Fig. 2), and N1a morphants exhibited abnormal
tail somite morphology at 28 hpf (Supp. Fig. 2), phenocopying
defects resulting from DAPT-mediated Notch pathway inhibition
(Geling et al., 2002) and those observed in notch1a mutants (van
Eeden et al., 1996; Amsterdam et al., 2004).
To ﬁrst determine if elevated Notch1a expression contributes to
the proliferation defects in Id2a-deﬁcient retinae, co-knockdown of
Id2a and Notch1a (Id2aMO/N1aMO) was performed, and resulting
retinae were examined at 48 hpf for the presence of pH3, a marker
of late G2/M. As shown previously (Uribe and Gross, 2010), Id2aMO
retinae contained fewer pH3-positive cells when compared toId2aMM retinae (Fig. 4A, B and F p¼0.015) and they were
microphthalmic, containing signiﬁcantly fewer cells than controls
(Fig. 4E; p¼0.001). N1aMO retinae exhibited no signiﬁcant differ-
ence in the percentage of pH3-positive cells when compared to
Id2aMM control (Fig. 4C and F, p¼0.62). In the double knockdown
condition, Id2aMO/N1aMO retinae recovered pH3 levels to that of
Id2aMM controls, exhibiting a signiﬁcant increase in the percen-
tage of pH3-positive cells over that in Id2aMO retinae alone
Fig. 4. Knockdown of Notch1a rescues retinoblast proliferation defects in Id2a-deﬁcient retinae. (A)–(D) pH3 immunohistochemistry was used to quantify retinoblasts in
late G2/M in transverse retinal sections from (A) Id2aMM, (B) Id2aMO, (C) N1aMO and (D) Id2aMO/N1aMO embryos at 48 hpf. Average total cell number per retinal section
was determined for each condition (E), as well as the average percentage of pH3-positive cells per retinal section (F). Dorsal is up in all images. Error bars represent SEM,
n¼9; *po0.05, ** po0.005.
R.A. Uribe et al. / Developmental Biology 371 (2012) 280–292 285(Fig. 4D and F; p¼0.02). Furthermore, average total cell number in
Id2aMO/N1aMO retinae was signiﬁcantly higher than that in Id2a
morphants (Fig. 4E; p¼ .003).
We next investigated if terminal differentiation could also be
rescued in Id2aMO/N1aMO knockdown retinae. As above, immu-
nohistochemistry was utilized to assay for the presence of
differentiated amacrine cells and red/green cones. As expected
at 72 hpf, Id2aMO retinae lacked amacrine cells and red/green
cones in comparison to Id2aMM controls (Fig. 5A–H), while
terminal differentiation of amacrine cells and red/green cones
appeared unaffected in N1aMO retinae (Fig. 5I–L, Gross et al.,
2005). Examination of terminal differentiation in Id2aMO/N1aMOretinae revealed a striking rescue of both amacrine cells and
red/green cones (Fig. 5M–P), indicating that a reduction in Notch
pathway activity, via loss of Notch1a, is sufﬁcient to restore the
presence of terminally differentiated neurons in an Id2a-deﬁcient
retina.
That Notch pathway genes were upregulated in Id2a-defcient
retinae and pharmacological or N1aMO-mediated inhibition of
Notch pathway activity rescued proliferation and terminal differ-
entiation defects in Id2a morphants suggests that Id2a activity is
necessary to limit Notch pathway activity during retinal devel-
opment. To further test this model, we next determined if Id2a
was sufﬁcient to restrict the expression of Notch pathway genes
Fig. 5. Knockdown of Notch1a rescues terminal differentiation of retinal neurons in Id2a-deﬁcient retinae. Transverse retinal sections from Id2aMM (A)–(D), Id2aMO
(E)–(H), N1aMO (I)–(L) and (M)–(P) Id2aMO/N1aMO embryos at 72 hpf assayed for 5e11 expression (amacrine cells) or Zpr1 expression (red/green cones). Merged images
show co-staining of retinal marker (blue) and nuclei (Sytox-green; green). Dorsal is up in all panels.
R.A. Uribe et al. / Developmental Biology 371 (2012) 280–292286during retinal neurogenesis. Examining a subset of the Notch
pathway genes upregulated in Id2a-deﬁcient retinae, qRT-PCR
demonstrated that the transcript levels of n1a, ascl1a, dla and
her4.1 were each signiﬁcantly reduced in retinae isolated from
id2a-overexpressing embryos at 33 hpf, when compared to levels
in gfp-injected controls (Fig. 6I). Spatially, while there was no
observable change in the distribution of n1a in id2a-injected
retinae when compared to controls (Fig. 6A and E); however,
the expression domains of ascl1a, dla and her4.1 were all more
restricted in id2a-injected retinae than in controls (Fig. 6C–H).
ascl1awas enriched at the retinal margins in control embryos, and
also observed throughout much of the central retina (Fig. 6B),
while in id2a-overexpressing embryos, ascl1a was absent from
much of the central retina (Fig. 6F). dla was expressed throughout
the control retina (Fig. 6C), whereas in id2a retinae, dla expression
was less pronounced within the central retina (Fig. 6G). Finally, in
control retinae the distribution of her4.1 was sharply conﬁned to
the ciliary marginal zones (Fig. 6D), while in id2a-overexpressing
retinae, her4.1 expression was barely detectable (Fig. 6H). These
observations indicate that Id2a is sufﬁcient to restrict the expres-
sion of Notch pathway genes during retinal development and
when combined with the Notch pathway inhibition experiments,
they support a model in which Id2a functions to limit Notch
pathway activity during retinal development.
Id2 is a helix-loop-helix factor incapable of directly binding
DNA; rather, it heterodimerizes with a variety of transcription
factors and transcriptional regulators thereby inﬂuencing expres-
sion of downstream targets (Benezra, 2001; Jogi et al., 2002).
Thus, its function in inﬂuencing Notch activity, if direct, must bemediated by some unidentiﬁed binding partners. It is also
possible that Id2a-dependent regulation of the Notch pathway
is indirect, whereby it regulates the expression of an intermediate
factor and/or pathway that then regulates Notch pathway activ-
ity. In an attempt to gain an unbiased, global view of gene
expression changes that occur as a result of Id2a deﬁciency in
the retina, we next utilized a novel RNA-sequencing (RNA-seq)
strategy to compare gene expression levels between Id2aMO and
Id2aMM retinae and identify gene expression changes resulting
from a deﬁciency in Id2a. Experimentally, RNA was isolated from
retinae dissected from 48–50 hpf Id2aMM or Id2aMO injected
embryos (lenses removed) and utilized for Illumina sequencing to
quantify transcript abundance in either condition (Fig. 7A). Over
100 million 2100 bp paired-end reads in two biological repli-
cates of both Id2aMM control retinae and Id2aMO knockdown
retinae were mapped to all known zebraﬁsh cDNA sequences
(Supplemental Table 1; see the Materials and methods section),
and differentially expressed (DE) transcripts between Id2aMM
and Id2aMO retinae were identiﬁed from these mapped reads.
Setting a threshold for differential expression of a two fold change
with signiﬁcance of adjusted po0.05, and a mean of normalized
RPK100M of either sample is greater than 500, 1877 DE transcripts
were identiﬁed (corresponding to 1255 genes) (Fig. 7B and C;
Supplemental Table 2).
Among the downregulated genes, factors involved in retinal
neuron differentiation and function exhibited the most dramatic
reduction in expression (Fig. 7D). These included genes that
encode for retinal photoreceptor cell proteins such as Rhodopsin
(rho), Opsin 1 medium-wave-sensitive (opn1lw2), Arrestin3a
Fig. 6. Id2a-overexpression is sufﬁcient to limit the retinal expression of Notch pathway component genes. Transverse sections reveal the expression domains for n1a,
ascl1a, dla and her4.1 at 33hpf in gfp-injected control (A)–(D) and id2a-overexpressing (E)–(H) embryos following in situ hybridization (n¼6 sectioned embryos/condition).
(I) qRT-PCR quantiﬁcation of ascl1a, n1a, dla and her4.1 levels in id2a retinas compared to gfp control retinas at 33 hpf. Transcript levels were normalized to tubulin, alpha 1
and the fold-change in expression in gfp-injected vs. id2a-injected retinae presented. Error bars represent SEM, **p o .05, n¼3 biological replicates.
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This is not surprising given the lack of terminally differentiated
neurons in Id2aMO retinae and served as an excellent internal
control for the RNA-Seq approach and DE analyses. Numerous
other genes of interest were noted within the DE downregulated
list; for example, several that encode proteins functioning in
signaling pathways that feed into the cell cycle such as Cyclin
dependent kinase inhibitor 1b (p27) (cdkn1b), Adenomatosis
polyposis coli (apc) and Mitogen-activated kinase 10 (mapk10).
Upregulated in Id2a-deﬁcient retinae were also a number of
relevant genes and pathways. Indeed, several genes encoding
proteins involved in cell cycle progression were upregulated in
Id2a-deﬁcient retinae, and these included Cyclin D1 (ccnd1),
Cyclin G1 (ccng1), Cyclin dependent kinase 6 (cdk6), Checkpoint
homologue 2 (chek2), S-phase kinase-associated protein 2 (skp2)and Cyclin dependent kinase inhibitor 1a (cdkI1a) (Fig. 7D). This
increase in cell cycle pathway components was also not surprising,
given Id2a’s role in modulating retinoblast cell cycle progression
(Uribe and Gross, 2010). In addition, several Wnt pathway compo-
nents were also upregulated. The Wnt pathway is known to
regulate the proliferative state of retinoblasts as well as their
neurogenic potential (Kubo et al., 2005; Agathocleous et al.,
2009). Transcripts encoding R-spondin homologue (rspo1), Frizzled
6 (fzd6) and Transcription factor 7-like 1b (tcf7l1b) were enriched in
Id2a-deﬁcient retinae (Fig. 7D). Rspo1 is a secreted Wnt pathway
agonist (Carmon et al., 2011), while Fzd6 is a Wnt receptor (Katoh,
2008) and Tcf7l1b (formerly known as Tcf3b) is a downstream
mediator of the Wnt pathway (Amoyel et al., 2005). qRT-PCR
validation of the RNA-seq dataset for a subset of the DE genes
(ccnd1, cdk6, skp2, cdkI1a, fzd6, rspo1 and tcf7I1b) indicated that
Fig. 7. RNA-Seq analysis of differential retinal gene expression resulting from Id2a-deﬁciency. (A) Schematic of RNA-Seq experiment. Whole retinas were dissected from
Id2aMM and Id2aMO embryos, their lenses were removed and total retinal RNA was extracted and used for Illumina RNA sequencing. 100 million Illumina reads were
obtained for each condition, and the experiment was repeated in two biological replicates for each condition (see the Materials and methods section for details). (B) The
number of reads per each transcript was normalized with total number of mapped reads and transcript length, converting all raw read counts to ‘number of reads per 1000
bases per 100 million reads’ (RPK100M). ‘100 million reads’ were chosen to get positive values of log10-transformed normalized values. A scatter plot shows the correlation
between Id2aMO and Id2aMM control normalized reads (Spearman¼0.95). Differentially expressed transcripts with fold changes greater than 2 and adjusted p-value less
than 0.01 are indicated with red dots. (C) Volcano plot illustrating that out of 42,389 mapped transcripts, 1914 were signiﬁcantly differentially expressed (DE), po0.01
(red dots), and, for visualization purposes, of those 962 were highly signiﬁcant, with an adjusted p-value o0.001 (blue dots). (D) A table depicting representative genes
that exhibit signiﬁcant changes in gene expression between Id2aMM and Id2aMO retinas; genes were categorized based upon known pathways and are color coded.
(E) qRT-PCR validation of RNA-Seq data for a subset of DE genes. Transcript levels of ccnd1, cdk6, skp2, cdkn1a, fzd6, rspo1 and tcf7l1b in Id2aMO retinae compared to
Id2aMM retinae at 48hpf. Transcript levels were normalized to tubulin and the fold-change in expression in Id2aMO retinae compared to Id2aMM retinae presented. Error
bars represent SEM, **po0.05, n¼3 biological replicates.
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those of Id2a-MM controls and supported the validity of the DE
dataset and thus, the RNA-Seq and bioinformatic approach (Fig. 7E).
Pathway and GO term enrichment tests of the DE genes, via
the DAVID program, identiﬁed various pathways and biological
processes affected by Id2a-deﬁciency (Supplemental Tables 3
and 4). For those genes downregulated in Id2a-deﬁcient retinae,
enriched pathways included the biological processes of ‘calcium
ion binding’ and ‘cell adhesion’ (Supplemental Table 3). Amongstthe upregulated genes, enriched pathways included ‘RNA proces-
sing’, ‘nitrogen compound biosynthesis’, ‘nucleotide biosynthesis’,
‘p53 signaling pathway’, ‘cell cycle’ and ‘DNA replication’
(Supplemental Table 4). In all, pathway enrichment analyses
revealed a number of potentially interesting pathways as being
inﬂuenced downstream of Id2a function during retinogenesis, and
as such, these identiﬁed pathways and genes should serve as
excellent candidates for future studies to determine how Id2a
mediates proliferation and differentiation during retinogenesis.
Fig. 8. Model for Id2a/Notch regulation of retinoblast proliferation and differ-
entiation. (A) Id2a negatively regulates Notch pathway component expression and
pathway activity. When active, the Notch pathway maintains retinoblasts in a
proliferative, progenitor state.
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The timing and distribution of Notch pathway activity is
fundamental in dictating the choice between proliferation and
neurogenesis during retinal development. Notch pathway activity
maintains retinal progenitor cells in a proliferative state in order
to ensure that there are sufﬁcient numbers of progenitors
available for successive waves of retinal neurogenesis (Henrique
et al., 1997; Cepko, 1999; Jadhav et al., 2006a). In mice, sustained
Notch activity within retinal progenitor cells leads to an upregu-
lation of multiple ‘‘progenitor’’ genes, such as Notch1, Fgf15 and
Ccnd1 (Jadhav et al., 2006a), and this correlates with the main-
tenance of a proliferative progenitor state. In contrast, when
Notch signaling activity is ectopically induced in newly post-
mitotic retinal cells, cells ultimately adopt a glial cell fate,
demonstrating that temporal control of Notch activity is also
critical during retinal development (Jadhav et al., 2006a). In the
zebraﬁsh retina, ectopic expression of a constitutively active
Notch1a variant impairs neuronal differentiation; retinal progenitor
cells either differentiate into glia or remain undifferentiated and
eventually undergo apoptosis (Scheer et al., 2001). Conversely,
Notch inhibition causes retinoblasts to prematurely exit the cell
cycle and differentiate into early born retinal cell types (Bernardos
et al., 2005).
Our previous study demonstrated that Id2a levels modulated
retinoblast cell cycle kinetics and that Id2a was required for the
terminal differentiation of late born retinal cell types, i.e., ama-
crine and bipolar neurons, rod and cone photoreceptors, and
Mu¨ller glia, phenotypes reminiscent of enhanced Notch activity.
Indeed, mosaic analyses revealed that these roles were cell non-
autonomous, indicating that Id2a functions upstream of extrinsic
regulators of retinal development (Uribe and Gross, 2010). In the
present study, we expanded on these observations and our data
support a model in which Id2a function is required to limit Notch
pathway activity during retinal development. The Notch ligand
genes dla and dlc; the Notch receptor gene n1a; and the Notch
pathway target genes ascl1a, her4.1 and hes6 were all signiﬁcantly
upregulated in retinae lacking Id2a. Conversely, the expression
levels of ascl1a, n1a, dla and her4.1 were downregulated in retinae
overexpressing id2a. dla, dlc and n1a are expressed in a graded
fashion along the apical-basal axis within the zebraﬁsh retinal
neuroepithelium and this graded localization is thought to dictate
the level of Notch signaling a retinoblast is exposed to during
interkinetic nuclear migration (IKNM) (Del Bene et al., 2008). Dll1,
orthologous to zebraﬁsh dla, is expressed in chicken retinoblasts
(Nelson and Reh, 2008; Nelson et al., 2009), and its ectopic
expression prevents retinal progenitor cells from differentiating
(Henrique et al., 1997). Regulated expression of each of these
factors is therefore critical to control the balance between pro-
liferation and differentiation in retinoblasts, and this balance is
disrupted in Id2a-deﬁcient retinae.
While the inverse relationship between Id2a levels and Notch
pathway components was not surprising, upregulation of hes6 in
Id2a-deﬁcient retinae was, given that Hes6 is typically associated
with proneural activity (Bae et al., 2000; Koyano-Nakagawa et al.,
2000). For example, in mouse retinal explants, ectopic expression of
Hes6 during late phases of retinogenesis causes retinal cells to
predominately differentiate into rod photoreceptors, by overcoming
Hes1-mediated repression of neurogenesis and biasing retinoblasts
towards neuronal fates (Bae et al., 2000). While we observed
increased hes6 expression in Id2a-deﬁcient retinae, Id2a-deﬁcient
retinae lack nearly all neurons and Mu¨ller glia, indicating that this
upregulation did not result in a proneural bias. Given the signiﬁcant
upregulation of other Notch pathway components, and antagonistic
interactions between these factors, it could be that the increase in
hes6 expression was not sufﬁcient to overcome the overall netincrease in Notch pathway activity within Id2a-deﬁcient retinae,
and thus, retinoblasts remained proliferative. Hes6 itself has also
recently been identiﬁed as a regulator of cell proliferation in glioma
cells (Haapa-Paananen et al., 2012), and it could also feasibly
function as a contributor to the overall enhanced proliferative state
of Id2a-deﬁcient retinoblasts.
Pharmacological inhibition of Notch pathway activity rescued
both proliferation and differentiation defects in Id2a-deﬁcient
retinae, as did knockdown of Notch1a expression, suggesting that
upregulation of Notch pathway activity contributes to the retino-
blast proliferation and differentiation defects in Id2a-deﬁcient
embryos. In Id2a-deﬁcient retinae, we previously reported that
crx expression was absent and cone photoreceptors failed to
differentiate (Uribe and Gross, 2010). Notch1 functions to sup-
press cone photoreceptor fates, at least in part, by suppressing the
expression of key transcription factors required for their genesis,
such as crx (Yaron et al., 2006). It could be that elevated Notch1a
levels within Id2a-defcient retinae inhibit the expression of genes
required for photoreceptor cell speciﬁcation and differentiation,
therefore abolishing photoreceptor production. In support of this
model, we found that knockdown of Notch1a in Id2a-deﬁcient
retinae was sufﬁcient to fully restore cone photoreceptor produc-
tion. Although our data do not rule out the possibility that Id2a
and Notch function within parallel pathways regulating retino-
blast proliferation and differentiation, the transcriptional changes
in Notch pathway gene expression occurring as a result of
modulating Id2a levels lead us to favor a model in which Id2a
acts upstream of the Notch pathway in a common gene regulatory
network governing retinogenesis, where Id2a serves to limit
Notch pathway activity (Fig. 8).
How would Id2a regulate Notch pathway gene expression in
such a network? If Id2a directly regulates the pathway, given that
Ids do not directly bind to DNA, Id2a’s effect would have to be
achieved by antagonizing a regulatory factor that ultimately
functions to positively drive the expression of Notch pathway
genes. We do not know to what factors Id2a binds in the zebraﬁsh
retina; however, Id3, an Id family member, is known to regulate
the expression of Notch1 in developing T cells and it is thought
that this occurs by Id3 binding to members of the bHLH complex
E2A, a heterocomplex of E12 and E47, thereby antagonizing E2A
formation and its ability to activate notch1 expression (Yashiro-
Ohtani et al., 2009). Id2 can bind to and sequester E12 and E47
proteins in ﬁbroblasts, thereby modulating the expression of cell
cycle regulators, indicating that Id2 has the capacity to inhibit
E2A heterocomplex formation (Trabosh et al., 2009). Id2a could
also sequester the bHLH protein Ascl1a, a Notch pathway target
gene itself, which functions to activate the expression of delta-like
and other Notch pathway targets in the retina (Nelson et al.,
2009). Indeed, numerous factors have been shown to regulate
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transcriptionally, and may of these also represent possible candi-
dates for Id2a antagonism. For example, in mouse and chicken
neuroepithelia, Notch1 and Dll1 transcripts are expressed in a cell
cycle dependent manner (Cisneros et al., 2008), and in mouse
neuroepithelial cell lines and knockouts, they are stabilized
during M-phase via interaction with Elavl1/HuR (Garcia-
Dominguez et al., 2011). In any of these scenarios, Id2a would
serve to antagonize the function of an immediate upstream
regulator of Notch pathway gene expression and thereby exert
its inﬂuence on Notch pathway gene expression and activity.
Importantly however, direct Id-Notch regulatory interactions are
also likely to be tissue speciﬁc as, for example, in olfactory bulb
development Id2 is required for dopaminergic neuron speciﬁca-
tion and Id2 knockouts possess decreased levels of Hes1
and Ascl1in their olfactory bulbs (Havrda et al., 2008). Thus,
Id-dependent antagonism is likely context dependent and deter-
mined by the interacting factors present in the Id-expressing
tissues (i.e., whether Ids are antagonizing positively acting or
negatively acting factors that then regulate Notch pathway gene
expression in this context dependent manner).
Downstream factors or pathways whose expression or activity
depends on Id2a function could also mediate the regulatory
network interactions between Id2a and the Notch pathway in
an indirect fashion. With this in mind, and to gain insight into
gene expression changes resulting from loss of Id2a function, we
utilized a novel RNA-Seq approach to identify differentially
expressed genes between Id2aMO and Id2aMM retinae. Upregu-
lated genes belonging to the ‘cell cycle’ and ‘Wnt pathway’ were
identiﬁed (Fig. 7, Supplemental Table 4), and downregulated
genes involved in the processes of ‘calcium ion binding’, ‘ion
transport’, ‘cell adhesion’ and ‘ion channel activity’ were identi-
ﬁed, among others (Supplemental Table 3).
The identiﬁcation of the cell cycle pathway as being inﬂuenced
downstream of Id2a correlates well with the proliferative defects in
Id2a-deﬁcient retinoblasts (Uribe and Gross, 2010) and with the
Id2a-dependent upregulated Notch pathway activity described
here. ccnd1, ccng1, cdk6, skp2, cdkn1a and chek2 were all signiﬁ-
cantly enriched within Id2a-deﬁcient retinae, while cdkn1b was
downregulated. Many of these factors have been shown to inﬂu-
ence, or be inﬂuenced by, Notch pathway activity (e.g., Sarmento
et al., 2005; Bienvenu et al., 2010; Ronchini and Capobianco, 2001).
Of particular interest in this group is CyclinD1; in addition to its
well-characterized role in regulating cell cycle progression, it also
possesses a transcriptional activator role and positively regulates
Notch1 expression in the retina (Bienvenu et al., 2010). The Notch
pathway feeds into positive regulation of CyclinD1 expression,
which then maintains a proliferative and undifferentiated state
(Ronchini and Capobianco, 2001).
Id2a-dependent regulation of cell cycle progression itself could
also contribute to the elevated Notch pathway activity in Id2a-
deﬁcient retinae. Skp2, S-phase kinase-associated protein 2, is an
important regulator of cell cycle maintenance because it promotes
the degradation of p21, p27 and p57 proteins (Chan et al., 2010). Skp2
expression can be activated directly by Notch signaling (Sarmento
et al., 2005) and by E2F transcription factors (Chan et al., 2010), and
thus elevated Skp2 levels would maintain Id2a-deﬁcient retinoblasts
in a proliferative state. Moreover, in the zebraﬁsh retinal neuroe-
pithelium there is an apical (high) to basal (low) gradient of Notch
activity, and during IKNM, progenitor nuclei are exposed to Notch-
dependent neurogenic versus proliferative signals based on their
location within each proliferating retinoblast (Del Bene et al., 2008).
Id2a-deﬁcient retinoblasts progress through the cell cycle more
slowly, with S to M phase progression signiﬁcantly delayed (Uribe
and Gross, 2010). While we have not quantiﬁed IKNM in Id2a-
deﬁcient retinae, it is possible that the delay in S to M phaseprogression manifests as a prolonged IKNM of Id2a-deﬁcient neuro-
blast nuclei, and in this scenario, Id2a-deﬁcient retinoblast nuclei
would spend longer periods of time apically and thus be exposed to a
higher duration of Notch signaling, resulting in the maintenance of a
progenitor state.
Wnt pathway gene expression was upregulated in Id2a-
deﬁcient retinae; rspo1, fzd6 and tcf7l1b were all expressed at
higher levels than in control retinae. The Wnt pathway is a key
regulator of retinogenesis (Kubo et al., 2005), and in Xenopus,
ectopic activation of the Wnt pathway inhibits retinal neuron
differentiation and maintains the retinal progenitor pool by
activating Notch signaling, indicating that there is crosstalk
between the Wnt and Notch pathways to regulate proliferation
and differentiation events in the retina (Agathocleous et al.,
2009). Rspo1 is a secreted positive regulator of Wnt signaling
events, but has not yet been implicated in retinal development
(MacDonald et al., 2009; Carmon et al., 2011).
In summary, our data support a model in which Id2a, an
intrinsic regulator of retinogenesis, acts upstream of the Notch
pathway to regulate the balance between proliferation and
differentiation during retinogenesis (Fig. 8). Alterations in Id2a
levels result in prolonged S to M phase progression during the
retinoblast cell cycle and a lack of terminal differentiation of
retinal neurons and glia. Notch pathway gene expression is
inversely correlated with Id2a levels, and blocking Notch pathway
activity pharmacologically or by targeting the Notch 1a receptor
rescues both proliferation and differentiation defects in Id2a-
deﬁcient retinae. Analysis of global gene expression changes
resulting from Id2a deﬁciency revealed that a number of regula-
tory pathways involved in modulating retinoblast proliferation
and differentiation were affected by loss of Id2a, and several of
these have known interactions with the Notch pathway. Future
studies analyzing these pathways, their dependence on Id2a and
their downstream effects on Notch activity will continue to shed
light on how the balance between proliferation and differentia-
tion is maintained in the retina in order to form a retina of proper
size and cell type composition.Acknowledgements
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